Their marketing and fund-raising approaches also seem to be completely different. I think this was good for both of them, especially if Dileep is licensing from

Their marketing and fund-raising approaches also seem to be completely different. I think this was good for both of them, especially if Dileep is licensing from Numenta. Win-win scenario.